Gentris opens biomarker shop in Shanghai

Morrisville, NC-based Gentris is setting up a new genomic biomarker testing service in Shanghai, a growing global hub for drug development. "Gentris is creating an international quality, global organization capable of providing genomic biomarker testing and biobanking services for clinical trials," said CEO Amelia Wall Warner. "In addition to commercial services, we are building collaborations with top Chinese research organizations, universities, and companies to accelerate drug development and innovation." Release | More

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.